Edition:
United Kingdom

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

29.29USD
18 Oct 2018
Change (% chg)

$-0.70 (-2.33%)
Prev Close
$29.99
Open
$29.92
Day's High
$30.11
Day's Low
$29.01
Volume
36,299
Avg. Vol
75,091
52-wk High
$35.48
52-wk Low
$21.27

Chart for

About

Theravance Biopharma, Inc. is a biopharmaceutical company. The Company is engaged in creating medicines for patients suffering from serious illness. The Company operates in the segment of discovery (research), development and commercialization of human therapeutics. The Company's pipeline of internally discovered product... (more)

Overall

Beta: 2.40
Market Cap(Mil.): $1,919.56
Shares Outstanding(Mil.): 53.83
Dividend: --
Yield (%): --

Financials

  TBPH.OQ Industry Sector
P/E (TTM): -- 30.92 33.69
EPS (TTM): -4.62 -- --
ROI: -57.04 14.76 14.30
ROE: -82.78 16.26 16.03

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $72.21 +0.39
The Medicines Company (MDCO.OQ) $27.24 -0.53
GlaxoSmithKline plc (GSK.L) 1,510.60 +16.20
AstraZeneca plc (AZN.L) 5,878.00 +18.00
Novartis AG (NOVN.S) CHF85.88 +1.60

Earnings vs. Estimates